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S U M M A R Y
Vaccine efﬁcacy (VE) can be affected by progressive antigenic drift or any new reassortment of inﬂuenza
viruses. To effectively track the evolution of human inﬂuenza A(H3N2) virus circulating in Hangzhou,
China, a total of 65 clinical specimens were selected randomly from outpatients infected by A(H3N2)
viruses during the study period from November 2009 to December 2013. The results of reduced VE and
antigenic drift of the correspondent epitopes (C–D–E to A–B) suggest that the current vaccine provides
suboptimal protection against the A(H3N2) strains circulating recently. Phylogenetic analysis of the
entire HA and NA sequences demonstrated that these two genes underwent independent evolutionary
pathways during recent seasons. The H3-based phylogenetic tree showed that a special strain A/
Hangzhou/A289/2012 fell in a cluster among viruses with reduced VE predominantly circulating in
2013. Our ﬁndings underscore a possible early warning for the circulation of A(H3N2) variants with
antigenic drift during the previous seasons.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The human inﬂuenza A(H3N2) virus was ﬁrst diagnosed in
1968 and continues to co-circulate with seasonal A(H1N1) or
A(H1N1)pdm09 virus in human populations.1,2 From November
2009 to December 2013, seven inﬂuenza epidemics occurred in
Hangzhou, China, ﬁve of which were due to A(H3N2) virus as the
predominant strain. Furthermore, the epidemics were sustained
almost exclusively by the A(H3N2) virus (72.09%, 217/301) in
2013. The aim of the present study was to characterize the
antigenic variability of the current A(H3N2) strains involving
the main epitopes for the human immune system, and to compare
the phylogeny of the two surface antigens hemagglutinin (HA) and
neuraminidase (NA).* Corresponding author. Tel.: +86 571 8517 6761.
E-mail address: junli.hz.cn@gmail.com (J. Li).
http://dx.doi.org/10.1016/j.ijid.2014.09.013
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Methods
Up to 5904 outpatients with an inﬂuenza-like illness (ILI)
visiting two tertiary hospitals were enrolled within the framework
of the national inﬂuenza surveillance network in Hangzhou from
November 2009 to December 2013 (Figure 1). A total of 65 clinical
specimens (65/466, 13.95%) were selected randomly from the
patients with a conﬁrmed A(H3N2) virus infection, representing
ﬁrst wave (August 2010 to December 2010, n = 8), second wave
(January 2012 to April 2012, n = 9), third wave (June 2012 to
September 2012, n = 8), fourth wave (January 2013 to September
2013, n = 10), and ﬁfth wave (October 2013 to December 2013,
n = 30) samples. Total RNA was extracted directly from the original
specimen using the RNeasy Mini Kit in a QIAcube extractor
(Qiagen, Germany). The HA and NA segments were ampliﬁed by
RT-PCR with speciﬁc primers, as described previously.3,4 The
sequences were deposited in GenBank (accession numbers
KM208505–KM208634). Phylogenetic trees were constructed by
neighbor-joining method with bootstrap analysis (n = 1000) usingciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Virological surveillance for inﬂuenza virus among the inﬂuenza-like illness (ILI) cases at two sentinel hospitals in Hangzhou during the 2009–2013 seasons. (A) The
number of samples from ILI patients every month. (B) The positive rate of seasonal inﬂuenza virus infections. (C) The number of cases for each subtype every month.
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formula E = 0.47  2.47  Pepitope based on the antigenic distance
parameter Pepitope.
6 The substitution rates of HA and NA sequences
were analyzed by Markov chain Monte Carlo (MCMC) method in
BEAST package 1.7.4.7
3. Results
Antiviral resistance substitutions were not found in NA of the
representative specimens from the different seasons. H3-based
phylogenetic analysis showed that all viruses analyzed belonged
to the A/Victoria/208/2009 clade. Furthermore, most of them fell
into group 3C, except the strains isolated from the ﬁrst wave in
2010, which segregated into a speciﬁc group 6. Throughout the
ﬁve consecutive seasons, a substitution rate of 6.806  103
(5.196–8.456  103) subs/site/year for the HA segment was
estimated, which is higher than the rate of 5.600  103 (4.164–
7.062  103) subs/site/year for NA (p < 0.01).
HA sequences from the ﬁrst wave were similar (identity range
98.24–98.59%) to the 2010–2012 northern hemisphere vaccine
strain. However, these sequences presented antigenic drifts mainly
in the correspondent epitopes of C (D69N, E296A), D (T228A,
I246 V, S230I), and E (K78E, Y110H). It is noteworthy that the value
of VE declined by more than half (Figure 2).
With respect to the ﬁrst wave stains, the viruses from the
subsequent four waves were characterized by sequences allcarrying the substitution N294K in epitope C. Since the vaccine
strain had been changed to A/Victoria/361/2011, the VE reduced
slightly during the seasons of 2011–2012. However, it dropped
sharply to 44.68% when the A(H3N2) virus reemerged in
2013. More substitutions occurred in epitope A (A154S, R158G,
and N161S) and epitope B (T144A/V and L173S). Some strains also
had additional changes in the epitope C (D69N) or epitope E
(R277Q). Interestingly, the correspondent epitopes of viruses
changed from the epitopes C–D–E to A–B during the 2011–2013
seasons.
4. Discussion
The ﬁrst objective of the present study was to deﬁne the
occurrence of A(H3N2) variants circulating in Hangzhou during
the 2009–2013 seasons. Our data enabled us to determine the
substitutions that accumulated in the epitopes of HA, which may
drive the antigenic drift of the virus. Vaccination is the principal
strategy to reduce the public health burden of inﬂuenza infections.
Most sequencing has focused on the HA1 domain of the HA gene,
where mutations have the greatest effect on the antigenic
structure.6,8 The reduced VE and antigenic drift of the correspon-
dent epitopes (C–D–E to A–B) suggest that the current vaccine
provides suboptimal protection against circulating A(H3N2)
strains in Hangzhou, China.
Figure 2. Analysis of the molecular evolution of seasonal inﬂuenza A(H3N2) strains from different epidemics. (A) Vaccine efﬁcacy against the current strains. The bars with
different lowercase letters differed signiﬁcantly (Tukey’s HSD, p < 0.05); error bars for observations: standard deviation. (B) Phylogenetic tree for the HA gene of the seasonal
inﬂuenza A(H3N2) strains with the pertinent reference strains. The tree was rooted with A/HongKong/1/1968 as outgroup. The reference sequences of World Health
Organization recommended vaccine strains for the northern hemisphere (A/Brisbane/10/2007 in the 2009–2010 season, A/Perth/16/2009 in the 2010–2012 season, and
A/Victoria/361/2011 in the 2012–2014 season), and several representative strains were downloaded from GenBank or the Global Initiative on Sharing All Inﬂuenza Data
(GISAID). The antigenic cluster to which wave they belong is indicated with different colors, and signature amino acid changes are annotated at the nodes of each cluster in
different colors according to their positions in the epitopes. Only bootstrap values >50% are shown. (C) Phylogenetic tree for the NA gene of the A(H3N2) strains analyzed.
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infrequent but severe pandemics have always been caused by novel
reassortments.9 Calculation of the substitution rates revealed faster
evolution in the HA gene than in the NA gene. The phylogeny
construction suggests that HA and NA underwent independent
evolutionary pathways during recent seasons. Some A(H3N2) strains
could not be distinguished on the basis of their HA genes but could be
assigned to different clades based on the NA segment. Comparison of
these two genes reveals possible reassortment among recent strains,
which is not easily discerned by examining the HA gene alone. The HA
sequence from a strain A/Hangzhou/A289/2012 detected in July 2012,
was segregated into the cluster among viruses with reduced VE
predominantly circulating in 2013 (Figure 2). Our ﬁndings underscore
a possible early warning for the circulation of A(H3N2) variants
with antigenic drift during the previous seasons.
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